How many insider declarations has Ezekowitz Alan filed?

Ezekowitz Alan has filed 3 public insider declarations with SEC (Form 4).

What is Ezekowitz Alan's role?

Ezekowitz Alan's reported role is not specified by the regulator across the filings.

Which companies does Ezekowitz Alan report trades for?

Ezekowitz Alan reports trades for 2 companies, including Septerna, Inc..

What is Ezekowitz Alan's declared buy vs sell volume?

Across the available history, declared buys total 131k€ and disposals 0.

← Executives ★ Sign in to follow

EA

Ezekowitz Alan

OFFICER

·SEC (Form 4)

Septerna, Inc.Fulcrum Therapeutics, Inc.

0

Total declarations

0

Companies

€130,875

▲ Purchases (2 ops.)

—

▼ Sales (1 ops.)

Insider track record

Other

Disclosed buys

2

Disclosed sells

1

T+90 hit rate

100%

T+90 mean return

+57.5%

Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.

Signal history

Browse the full record of transactions filed by Ezekowitz Alan. Director active across 2 companies, notably Septerna, Inc.. In total, 3 disclosures have been logged. Split: 2 buys · 1 sell. Total volume traded: €131k. History available since 4 March 2025. The latest transaction was disclosed on 7 March 2025 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.

Companies and markets linked to Ezekowitz Alan

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Septerna, Inc. (US)Fulcrum Therapeutics, Inc. (US)

Declarations3 total

▼

Ezekowitz Alan

DirectorExecutives26 Jun 2026Fulcrum Therapeutics, Inc.

16SEC ↗

18,000 sharesCommon StockSEC:0001193125-26-290622:0

▲

Ezekowitz Alan

DirectorExecutives7 Mar 2025Septerna, Inc.

$92,27042SEC ↗

13,319 shares@ US$6.927765.4% of flowCommon StockSEC:0000950170-25-036321:0

Canonical exit: 5 Jun 2025 (T+90)

▲

Ezekowitz Alan

DirectorExecutives4 Mar 2025Septerna, Inc.

$47,54436SEC ↗

7,491 shares@ US$6.346834.6% of flowCommon StockSEC:0000950170-25-035064:0

Canonical exit: 2 Jun 2025 (T+90)

3 of 3 declarations

InsidersTradesSigma

← Executives ★ Sign in to follow

EA

Ezekowitz Alan

OFFICER

·SEC (Form 4)

Septerna, Inc.Fulcrum Therapeutics, Inc.

0

Total declarations

0

Companies

€130,875

▲ Purchases (2 ops.)

—

▼ Sales (1 ops.)

Insider track record

Other

Disclosed buys

2

Disclosed sells

1

T+90 hit rate

100%

T+90 mean return

+57.5%

Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.

Signal history

Browse the full record of transactions filed by Ezekowitz Alan. Director active across 2 companies, notably Septerna, Inc.. In total, 3 disclosures have been logged. Split: 2 buys · 1 sell. Total volume traded: €131k. History available since 4 March 2025. The latest transaction was disclosed on 7 March 2025 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.